Allyx Therapeutics, Inc.

CIK 1865257 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Allyx Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
May 11, 2026D0001865257-26-000004
Mar 3, 2026D0001865257-26-000003
Feb 10, 2023D0001865257-23-000001
Jun 2, 2021D0001865257-21-000001